Navneet Singh, MD

Posted: August 2018

Navneet Singh, MD, the IASLC’s Regent from India, has been appointed chair of the IDEA working group for the American Society of Clinical Oncology. Dr. Singh will serve a 2-year term. Dr. Singh is also on the IASLC’s Staging Committee, and he leads the multidisciplinary thoracic oncology group at PGIMER, where he specializes in targeted therapies and immunotherapies for advanced NSCLC.